• Profile
Close

Duloxetine 60 mg for chronic low back pain: Post hoc responder analysis of double-blind, placebo-controlled trials

Journal of Pain Research Aug 12, 2017

Alev L, et al. – Researchers planned this study to investigate the predictors of response to duloxetine for chronic low back pain (CLBP). They concluded that early pain reduction was suggestive of an overall response. Compared to patients with isolated CLBP, patients with multiple painful sites had more benefit from duloxetine.
Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay